IN REACTIVE germinal centres, there are 2 main morphological types of lymphoid germinal-centre cells (GCC):
(1) Centroblasts medium-sized or large cells with a round or oval, pale nucleus containing 2-3 nucleoli, usually located at the nuclear membrane; cytoplasm is sparse and intensely basophilic (Lennert, 1957 (Lennert, , 1961 .
(2) Centrocytes small or mediumsized cells with a cleaved or irregularly shaped nucleus; cytoplasm is usually sparse and very weakly basophilic and thus difficult to recognize in sections (Lennert, 1964) . Except in newly formed germinal centres, centrocytes are the predominant cells. Both types of GCC are B cells. Most GCC express Ia-like antigen (own unpublished data). Only some GCC bear surface immunoglobulin (SIg) (Gutman & Weissman, 1972; Goldschneider & McGregor, 1973; Hoffmann-Fezer et al., 1976 ; own unpublished data) and a few GCC contain cytoplasmic immunoglobulin (CIg); these usually resemble centrocytes (Stein & Tolksdorf in press ). Characteristically, GCC express complement receptors, which was first demonstrated by Dukor et al. (1970) . Those investigators showed that erythrocyte-antibody-complement complexes (EAC) prepared with whole mouse serum (EACmouse) as complement source adhered exclusively to germinal centres. Recently, our research group analysed the presence and distribution of D)r H. Steiin, Institute of Patliology, University of the complement-receptor subtypes (receptors for C3b and C3d) in reactive lymphoid tissue (Stein et al., 1978b) . We found that GCC bear both complement-receptor subtypes. The expression of both subtypes proved to be highly characteristic of GCC. It has become evident that reactive germinal centres have a neoplastic equivalent, viz.: a lymphoma that is composed of both centroblast-like and centrocytelike cells with a predominance of centrocyte-like cells, as have most germinal centres (Lennert, 1964 (Lennert, , 1973 Lennert et al., 1975a, b) . In 95% of the cases, the tumour shows a follicular growth pattern and has thus been called "follicular lymphoma". Recently, the term "malignant lymphoma (ML) centroblastic/ centrocytic" was introduced (GerardMarchant et al., 1974; Lennert et al., 1975a) because the cytological composition of the lymphoma is more consistent than the follicular growth pattern (which was absent in about 5% of our cases). Doubts about the close relationship between this tumour and germinal centres were eliminated by the demonstration of complement receptors on the neoplastic follicles, with a distribution and density similar to that of the complement receptors on reactive germinal centres (Jaffe et al., 1974; Stein, 1976) . More convincing arguments in favour of the close relationship between centroblastic/centrocytic lymphoma (CB/ CC) and germinal centres were provided by the similar expression and distribution of the 2 complement-receptor subtypes in CB/CC and follicular hyperplasia (Stein et al., 1978a, b) .
In this paper, we describe a type of lymphoma that is probably also derived from GCC, but, in contrast to CB/CC, is composed of only one type of GCC, i.e., of cells that resemble centrocytes of reactive germinal centres. We shall present immunological data that confirm the close relationship between the centrocyte-like tumour cells and reactive centrocytes. Preliminary data on this type oflymphoma have been reported in a number of previous papers (Lennert et al., 1975a, b; Stein, 1976 Stein, , 1978 Lennert & Mohri, 1978; Stein et al., 1978a Biopsy specimens obtained in Kiel were cut into 3 pieces immediately after surgical removal. Imprints were made from the fresh cut surface. One piece was fixed in formalin, cryosections were prepared from the second piece, and a cell suspension was prepared from the third piece. Biopsies taken in hospitals outside Kiel (up to 700 km away) were cut into 2 pieces after surgical removal and imprints were made from the fresh cut surface. One piece was placed in formalin and the other in sterile tissueculture medium cooled with ice in a Dewar bottle. The material was then sent to our laboratory by over-night rail express. After arrival in the morning, the piece in tissueculture medium was cut into 2 pieces when it was large enough. One of these 2 pieces was used for preparing cryosections and the other for cell suspensions.
Blood samples were supplemented with heparin (1 ml Thrombo vetren®, Promonta, Hamburg, Germany). Heparinized blood samples from outside Kiel were sent by rail express to our laboratory in 20 ml syringes cooled with ice in a Dewar bottle. Light microscopy. The piece of tissue that had been fixed in 100% formalin was embedded in paraffin. Sections were cut at 4 ,um and stained with haematoxylin and eosin (H and E), Giemsa (Merck, Darmstadt, Germany) periodic-acid Schiff (PAS) and silver impregnation (Goinori). Tissue imprints were stained with Pappenheim. For cytological characterization of suspended cells and cytological identification of cells subjected to rosette assays, cytocentrifuge slides were prepared and stained with Pappenheim.
Frozen sections. 10 um cryostat sections were cut from 1 part of the fresh unfixed biopsy specimen and lyophilized at 10-2 mmHg and -68°C. The lyophilized sections wNere kept at -90TC until use.
Cell suspensions.-One unfixed piece of the biopsy specimen was finely minced and passed through a plastic mesh. The filtered lymphoid cells w%Nere then separated from red blood cells, cell debris and interstitial tissue components, by density-gradient centrifugation (Boyum, 1968 Vossen (1975) . Anti-Ta-like serum was obtained from Alpha Gamma Labs (Sierra Madre, California, U.S.A). The characteristics of the antiserum have been described in detail elsewhere (Billing et al., 1976 Sternberger et al. (1970) as modified by Taylor (1974) . The procedure has been described in detail by Papadimitriou et al. (1978) .
RESULTS

Morphological findings
Histology. In the 9 cases investigated, the normal architecture of the lymph node was completely replaced by lymphoma cells. All cases showed a diffuse growth pattern. Numerous small vessels (capillaries and arterioles) were visible among the tumour cells. Epithelioid venules were generally absent. The small vessels were often surrounded by sheets of hyalin material. Thick fibres were seen, especially around the vessels.
In all cases, the vast majority of cells were small or medium-sized centrocytelike cells (Fig. la) . Cytoplasm was sparse and hardly visible. The cleaved or indented nuclei contained relatively sparse chromatin and often displayed one, or sometimes up to 3 small central nucleoli (Fig. lb-d) . All the tumours were completely devoid of centroblast-like cells and follicle mantle lymphocyte-like cells. In 2 tumours a small number of plasma cells of the Marschalko type, wbich were obviously reactive (polyclonal Jg pattern) were present in small foci and were also scattered throughout the lymph node. In all other cases few apparently reactive plasma cells could be identified.
Cytology. Cytological examination was made on tissue imprints and cytocentrifuge slides prepared from tumour-cell suspensions. The typical cytological features of the tumour cells were clearly visible in the cytocentrifuge slides, usually much better than in lymphnode imprints.
The nuclei of most tumour cells showed a characteristically irregular shape and were cleaved or sometimes even lobed (Fig. 2) . They contained moderately condensed chromatin and usually up to 3 small or medium-sized pale nucleoli, which were often surrounded by a distinct rim of well-condensed chromatin. The cells had only a small amount of pale-blue cytoplasm. The tumour cells isolated from peripheral blood showed identical cytological features.
Immunologicalfindinys (Tables I and II ) Surface immunoglobulin.-In every case studied, SIg was present on a large proportion of the tumour cells (Table I) . The fluorescent staining for SIg was usually very intense. Specification of the light chains showed a restriction to one light-chain type in 6 (K in 5 and A in one case) of the 9 cases tested. In the other 3 cases, both light-chain types were detectable on tumour cells. Heavy chains (t , 8) y, and o) were specified in 4 cases. In one case, we found none of the specified heavy chains, although most of the tumour cells showed intense staining for K. In the other 3 cases, both pu and y chains were demonstrable on tumour cells. Two of the 3 ,u-and y-positive cases showed staining for both K and A. In the third case, the SIg was restricted to K. Delta chains were absent from a vast majority of the tumour cells in all 4 cases.
Cytoplasmic immunoglobulin. In all 9 cases investigated, the tumour cells were consistently negative for CIg (Table II) . In 2 cases, there were a few ,u-or ypositive plasma cells of the Marschalko type, which were polyclonal, since they were not restricted to one light-chain type.
Ia-like antigen. Histology.-CB/CC, which is roughly equivalent to follicular lymphoma, imitates follicular hyperplasia. Centroblasts and centrocytes always proliferate side by side, but with a predominance of centrocytes. In B-CLL, the proliferating cells are lymphocytes and a few larger cells, which are usually grouped together to form light-appearing areas that are highly characteristic of B-CLL. Such light areas are not seen in T-CLL. We diagnose B-PLL by the criteria given by Galton et al. (1974) . Two out of the 5 cases of B-PLL revealed tartrate-resistant acidphosphatase activity in a variable proportion of the leukaemic cells.
Immunological findings.-The immunological data on CB/CC, B-CLL, B-PLL, and centrocytic lymphoma are summarized in Table III The lymphomas with the above morphological characteristics revealed remarkably uniform immunological features, whether tumour cells from lymph nodes or from peripheral blood were examined. After labelling of the cells with fluorescent anti-Ig sera, the usually strong fluorescence reflected relatively large amounts of SIg. In 6/9 cases, the staining pattern was clearly monotypic (positive for only one light-chain type), in agreement with previously reported data on 14 cases (Stein, 1978) . In that study, the SIg staining was restricted to one light-chain type in only 9 of the 14 cases. Other authors have reported large amounts of SIg restricted to one light-chain type in all or most cases of ML poorly differentiated (Hopper, 1974; Preud'Homme et al., 1974; Aisenberg & Long, 1975; Brouet et al., 1975) ML intermediate differentiation (Berard et al., 1978) or follicularcentre cell (FCC) lymphoma, small and large cleaved, diffuse (Leech et al., 1975) . At least some of the cases described by those authors are equivalent to the type of lymphoma under discussion here. Like the tumour cells of CB/CC (follicular lymphoma), those of the lymphoma type described here bore a relatively dense layer of SIg. Reactive GCC usually do not show such a high density of SIg. The reason for this discrepancy has not yet been found.
In all cases stained for CIg by the PAP method, the tumour cells were consistently negative, indicating no synthesis of secretory Ig. This finding concurs with the lack of secretory organelles (ergastoplasm) in the tumour cells (Kaiserling, 1978) and the usually decreased levels of serum Ig (Stein, 1976) .
In the 4 cases tested, Ia-like antigen was demonstrable in a variable proportion of the cells. The presence of Ia-like antigen and SIg proves the B-cell nature of the tumour cells.
The proportion of mouse E-rosetteforming cells was consistently small, even after treatment of the tumour cells with neuraminidase. This finding agrees with data on cases of lymphosarcoma-cell leukaemia reported by Catovsky et al. (1976) ; lymphosarcoma-cell leukaemia might be roughly equivalent to the type of lymphnode tumour described in this report. In their inability to bind mouse E, the tumour cells resemble centrocytes of reactive germinal centres (own unpublished data).
Complement receptors were expressed in all 13 cases analysed. Complementreceptor subtypes (receptors for C3b and C3d) were specified in 11 of those, in all of which both complement-receptor subtypes could be demonstrated on the tumour cells. The percentages of C3b receptor-positive and C3d receptor-positive tumour cells were about equal in all but one case. In that exception, there was a definite preponderance of EAC3b-reactive cells over EAC3d-reactive cells. These findings, obtained on cell suspensions, agree with our earlier data and with the demonstration of complement-receptor subtypes on frozen tissue sections from 4 cases. In 3 of those both EAC3b and EAC3d, and in the fourth, only EAC3b adhered to the sections. We may conclude from the results presented here that (a) the simultaneous presence of both complement-receptor subtypes is highly characteristic of the lymphoma cells under discussion, and (b) occasionally, C3d receptors are decreased in number, or even absent.
The presented data on complementreceptor subtypes are interesting in connection with our recent observations on the occurrence and distribution of complement receptor subtypes in follicular hyperplasia (Stein et al., 1978b) . We found that EAC(3d usually adhered to germinal centres and the follicular mantle, whereas EAC3b adhered not only to germinal centres and the follicular mantle, but also to parafollicular areas and, in many instances, to interfollicular areas, but spared the T-dependent paracortical zone. In rare instances, however, we observed germinal centres with small areas to which only EAC3b and no, or reduced amounts of, EAC3d were bound. Cytological evaluation of EAC3b-and EAC3d-binding tonsil cells on cytocentrifuge slides confirmed that cells exhibiting the typical features of GCC usually express both complement-receptor subtypes. Taking the data on follicular hyperplasia into consideration, we may conclude that the lymphomas showing both complement receptor subtypes are most likely derived from GCC. The cells of the 2 cases that showed a predominance or exclusive expression of C3b receptors might be related to GCC that express only C3b and no, or only reduced amounts of, C3d receptors.
Further evidence of a relationship between the type of lymphoma cell described here and GCC has been provided by electron-microscopical investigations (Kaiserling, 1978) . In 12/20 isomorphic cases, dendritic reticulum cells were demonstrable among the tumour cells. Dendritic reticulum cells appear to be restricted to the lymphnode cortex, in which the germinal-centre reaction takes place (Milanesi, 1965; Mitchell & Abbot, 1965; Nossal et al., 1968; Lennert & Niedorf, 1969; Veldman, 1970) .
In conclusion, both the morphological and the immunological findings suggest that the type of lymphoma described here is a separate entity. It appears to be a monoclonal proliferation of the GCC that we call "centrocytes", which led to the term "ML centrocytic".
Centrocytic lymphoma, as it is described here, is not found as a separate entity in other classifications. In former German and other European classification concepts, it was often grouped together with other lymphomas under the term "lymphocytic lymphosarcoma" and the leukaemic cases were placed under "leukosarcomatosis" or sometimes "CLL". According to Rappaport's (1966) classification, cases of centrocytic lymphoma would be diagnosed as either ML lymphocytic, well differentiated, or ML lymphocytic, poorly differentiated. In the classification of Lukes & Collins (1975) (Jaffe et al., 1974; Lukes & Collins, 1975; Stein et al., 1978b) justifies separating these types of lymphoma. Briefly, CB/CC consistently differs from centrocytic lymphoma in the composition of the tumour; CB/CC is a mixed proliferation of centrocytes (predominant in number) and centroblasts. CB/CC also differs from centrocytic lymphoma in the follicular growth pattern, the presence of a number of mouse E-rosetting cells, and the presence of a relatively large proportion of T cells (see Table III ). There is also a difference in prognosis: patients with CB/CC survive longer than patients with centrocytic lymphoma (Brittinger, 1978 Abbreviations as in Table II. rosetting cells, and the predominance of C3d receptor-bearing cells over C3b receptor-bearing cells (see Table III ).
Furthermore, B-CLL and centrocytic lymphoma differ in clinical behaviour and prognosis (Brittinger, 1978) . B-PLL is the only disorder that is not always clearly distinguishable from centrocytic lymphoma by immunological methods. The tumour cells of B-PLL bear a dense layer of SIg, lack CIg, express a variable number of complement receptors of both subtypes and lack mouse E-receptors; B-PLL thus resembles centrocytic lymphoma immunologically (see Table III ). B-PLL has to be differentiated from centrocytic lymphoma by cytological criteria and clinical behaviour, or by detection of tartrateresistant acid phosphatase activity.
Centrocytic lymphoma is easily distinguishable morphologically from all other types of non-Hodgkin's lymphoma of B-cell type that were not discussed here, viz.: lymphoplasmacytic/-cytoid lymphoma (LP immunocytoma), lymphoblastic lymphoma of the Burkitt type and of the unclassified type, and immunoblastic lymphoma (large-cell lymphoma). It should be mentioned, however, that the morphological differential diagnosis between centrocytic lymphoma and lymphoblastic lymphoma of the convoluted-cell type is sometimes difficult, because the "convolutions" of the nuclei in lymphoblastic lymphoma of the convoluted-cell type are not always clearly distinguishable in histological sections from the "cleavage" or "indentations" of the nuclei in centrocytic lymphoma. In such cases, these 2 types of lymphoma can be clearly differentiated by the acid-phosphatase reaction, or the more reliable immunological assays: lymphoblastic lymphoma of the convoluted-cell type shows focal acidphosphatase activity and is SIg-and sheep E-rosette-positive in most cases, and is human T-lymphocyte antigenpositive in all cases Thiel et al., 1977) .
In summary, the morphological and immunological data presented here and compared with those on other known entities, not only justify, but compel the separation of the type of lymphoma described in this paper as a distinct entity. Since the tumour cells are highly similar to centrocytes of reactive germinal centres (cleaved nuclei, presence of SJg and both complement-receptor subtypes, and absence of receptors for mouse E) we consider this lymphoma entity to be closely related to, or even derived from, centrocytes.
